ARTICLE

FindCenter AddIcon

Ketamine for Depression Still Too Expensive for Widespread Use

By Technology Networks — 2020

A paper authored by researchers from McLean Hospital has determined that esketamine, a nasal spray to treat severe depression, is currently too expensive for widespread use. The study compared the costs and benefits of esketamine, an antidepressant approved by the U.S. Food and Drug Administration (FDA) last year for use in treatment-resistant major depressive disorder.

Read on www.technologynetworks.com

FindCenter Post-Image

The Top Mental Health Challenges Facing Students

Experts and researchers use terms like “epidemic” and “crisis” to characterize the mental health challenges currently facing American college students. Statistics back up these claims.

FindCenter AddIcon
FindCenter Post-Image

Investors and Entrepreneurs Need to Address the Mental Health Crisis in Startups

The most brilliant and creative amongst us are sometimes the most troubled, and nowhere is that clearer than in the entrepreneurial ecosystem.

FindCenter AddIcon
FindCenter Post-Image

Reclaiming Lost Talent by the Millions

It’s time to treat the chronic brain disease called addiction.

FindCenter AddIcon

EXPLORE TOPIC

Clinical Depression